Kezar Life Sciences, Inc. (KZR)
6.28
+0.04
(+0.64%)
USD |
NASDAQ |
Dec 15, 16:00
6.28
0.00 (0.00%)
After-Hours: 19:43
Kezar Life Sciences Free Cash Flow: -56.66M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Artiva Biotherapeutics, Inc. | -78.90M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.83M |
| Cash from Investing (Quarterly) | 15.71M |
| Cash from Financing (Quarterly) | -1.305M |
| Free Cash Flow Per Share (Quarterly) | -1.342 |
| Free Cash Flow to Equity (Quarterly) | -7.669M |
| Free Cash Flow to Firm (Quarterly) | -9.83M |
| Free Cash Flow Yield | -123.4% |